Business Wire

U.S. Food and Drug Administration Approves Camzyos™ (mavacamten) for the Treatment of Adults With Symptomatic New York Heart Association Class II-III Obstructive Hypertrophic ...

Camzyos is the first and only FDA-approved cardiac myosin inhibitor that specifically targets the source of obstructive HCM PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today ...
EurekAlert!

Nordic walking improves functional capacity in people with heart disease

Philadelphia, June 15, 2022 – Researchers identified a greater increase in functional capacity, the ability to perform activities of daily living, as a result of Nordic walking in patients with ...
The American Journal of Managed Care

Factors That Determine VO2 Max Importance as Measure of Heart Failure Severity

Right ventricular systolic function evaluated through VO2 max is a more accurate measure of functional capacity of persons with heart failure compared with left ventricular systolic function. This ...
TCTMD

Intravenous Iron, Not Oral, Improves Functional Capacity in HF Patients

NEW ORLEANS, LA—Two new studies testing iron supplementation in patients with heart failure (HF) have yielded opposite findings, although experts say the differences are likely explained by how the ...
The American Journal of Managed Care

Patients With HFrEF, HFpEF See Different Functional Capacity Benefits With Dapagliflozin

The DETERMINE-Reduced and DETERMINE-Preserved trials demonstrated varying benefits of dapagliflozin on Kansas City Cardiomyopathy Questionnaire Total Symptom Score and Physical Limitation Scale as ...
clinicaladvisor.com

Type 2 Diabetes and Stage B HF Associated With Impaired Functional Capacity

There is impaired functional capacity in patients with type 2 diabetes and stage B heart failure characteristics. Patients with type 2 diabetes and stage B heart failure characteristics have impaired ...